Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Chiricozzi A, De Simone C, Fossati B, Peris K. Psoriasis: Targets and Therapy. 2019;9:29–35.The authors of this paper have advised us that by mistake they uploaded the wrong figure files for Figures 2 and 3 which had not been correctly updated.Read the original article
Guardado en:
Autores principales: | Chiricozzi A, De Simone C, Fossati B, Peris K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50f5579bcb284396ac3de83b8b27d3b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi A, et al.
Publicado: (2019) -
Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer S, et al.
Publicado: (2015) -
Emerging treatment options for psoriasis
por: Taheri A, et al.
Publicado: (2014) -
Critical appraisal of adalimumab in the treatment of chronic plaque psoriasis
por: Nicolazzo D, et al.
Publicado: (2014) -
Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options
por: Haroon M, et al.
Publicado: (2013)